▶ 調査レポート

世界の泌尿器科用薬市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Urology Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

が調査・発行した産業分析レポートです。世界の泌尿器科用薬市場 2021:企業別、地域別、種類・用途別 / Global Urology Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-105X14842資料のイメージです。• レポートコード:GIR-105X14842
• 出版社/出版日: / 2021年5月
• レポート形態:英文、PDF、84ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:Pharma & Healthcare
• 販売価格(消費税別)
  Single User¥522,000 (USD3,480)▷ お問い合わせ
  Multi User¥783,000 (USD5,220)▷ お問い合わせ
  Corporate User¥1,044,000 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、泌尿器科用薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。泌尿器科用薬の種類別市場規模(Α(アルファ)遮断薬、5α-レダクターゼ阻害薬)、用途別市場規模(病院、クリニック、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・泌尿器科用薬の市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Astellas、Endo、GP Pharm、Tolmar
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:Α(アルファ)遮断薬、5α-レダクターゼ阻害薬
・用途別分析2016年-2026年:病院、クリニック、その他
・泌尿器科用薬の北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・泌尿器科用薬のヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・泌尿器科用薬のアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・泌尿器科用薬の南米市場規模2016年-2026年:ブラジル、アルゼンチン
・泌尿器科用薬の中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Urology Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Urology Drugs size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Urology Drugs market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Urology Drugs market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Α (alpha) Blockers
5 α-reductase Inhibitors

Market segment by Application can be divided into
Hospital
Clinic
Others

The key market players for global Urology Drugs market are listed below:
Astellas
Endo
GP Pharm
Tolmar

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Urology Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Urology Drugs, with price, sales, revenue and global market share of Urology Drugs from 2019 to 2021.
Chapter 3, the Urology Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Urology Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Urology Drugs market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Urology Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Urology Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Urology Drugs Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Α (alpha) Blockers
1.2.3 5 α-reductase Inhibitors
1.3 Market Analysis by Application
1.3.1 Overview: Global Urology Drugs Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Urology Drugs Market Size & Forecast
1.4.1 Global Urology Drugs Sales in Value (2016-2026))
1.4.2 Global Urology Drugs Sales in Volume (2016-2026)
1.4.3 Global Urology Drugs Price by Type (2016-2026) & (USD/Kg)
1.5 Global Urology Drugs Production Capacity Analysis
1.5.1 Global Urology Drugs Total Production Capacity (2016-2026)
1.5.2 Global Urology Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Urology Drugs Market Drivers
1.6.2 Urology Drugs Market Restraints
1.6.3 Urology Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Astellas
2.1.1 Astellas Details
2.1.2 Astellas Major Business
2.1.3 Astellas Urology Drugs Product and Services
2.1.4 Astellas Urology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Endo
2.2.1 Endo Details
2.2.2 Endo Major Business
2.2.3 Endo Urology Drugs Product and Services
2.2.4 Endo Urology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 GP Pharm
2.3.1 GP Pharm Details
2.3.2 GP Pharm Major Business
2.3.3 GP Pharm Urology Drugs Product and Services
2.3.4 GP Pharm Urology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Tolmar
2.4.1 Tolmar Details
2.4.2 Tolmar Major Business
2.4.3 Tolmar Urology Drugs Product and Services
2.4.4 Tolmar Urology Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Urology Drugs Sales by Manufacturer
3.1 Global Urology Drugs Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Urology Drugs Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Urology Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Urology Drugs Manufacturer Market Share
3.4.2 Top 6 Urology Drugs Manufacturer Market Share
3.5 Global Urology Drugs Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Urology Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Urology Drugs Market Size by Region
4.1.1 Global Urology Drugs Sales in Volume by Region (2016-2026)
4.1.2 Global Urology Drugs Revenue by Region (2016-2026)
4.2 North America Urology Drugs Revenue (2016-2026)
4.3 Europe Urology Drugs Revenue (2016-2026)
4.4 Asia-Pacific Urology Drugs Revenue (2016-2026)
4.5 South America Urology Drugs Revenue (2016-2026)
4.6 Middle East and Africa Urology Drugs Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Urology Drugs Sales in Volume by Type (2016-2026)
5.2 Global Urology Drugs Revenue by Type (2016-2026)
5.3 Global Urology Drugs Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Urology Drugs Sales in Volume by Application (2016-2026)
6.2 Global Urology Drugs Revenue by Application (2016-2026)
6.3 Global Urology Drugs Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Urology Drugs Sales by Type (2016-2026)
7.2 North America Urology Drugs Sales by Application (2016-2026)
7.3 North America Urology Drugs Market Size by Country
7.3.1 North America Urology Drugs Sales in Volume by Country (2016-2026)
7.3.2 North America Urology Drugs Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Urology Drugs Sales by Type (2016-2026)
8.2 Europe Urology Drugs Sales by Application (2016-2026)
8.3 Europe Urology Drugs Market Size by Country
8.3.1 Europe Urology Drugs Sales in Volume by Country (2016-2026)
8.3.2 Europe Urology Drugs Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Urology Drugs Sales by Type (2016-2026)
9.2 Asia-Pacific Urology Drugs Sales by Application (2016-2026)
9.3 Asia-Pacific Urology Drugs Market Size by Region
9.3.1 Asia-Pacific Urology Drugs Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Urology Drugs Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Urology Drugs Sales by Type (2016-2026)
10.2 South America Urology Drugs Sales by Application (2016-2026)
10.3 South America Urology Drugs Market Size by Country
10.3.1 South America Urology Drugs Sales in Volume by Country (2016-2026)
10.3.2 South America Urology Drugs Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Urology Drugs Sales by Type (2016-2026)
11.2 Middle East & Africa Urology Drugs Sales by Application (2016-2026)
11.3 Middle East & Africa Urology Drugs Market Size by Country
11.3.1 Middle East & Africa Urology Drugs Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Urology Drugs Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Urology Drugs Typical Distributors
12.3 Urology Drugs Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Urology Drugs Revenue by Type, (USD Million), 2021-2026
Table 2. Global Urology Drugs Revenue by Application, (USD Million), 2021-2026
Table 3. Astellas Basic Information, Manufacturing Base and Competitors
Table 4. Astellas Major Business
Table 5. Astellas Urology Drugs Product and Services
Table 6. Astellas Urology Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Endo Basic Information, Manufacturing Base and Competitors
Table 8. Endo Major Business
Table 9. Endo Urology Drugs Product and Services
Table 10. Endo Urology Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. GP Pharm Basic Information, Manufacturing Base and Competitors
Table 12. GP Pharm Major Business
Table 13. GP Pharm Urology Drugs Product and Services
Table 14. GP Pharm Urology Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Tolmar Basic Information, Manufacturing Base and Competitors
Table 16. Tolmar Major Business
Table 17. Tolmar Urology Drugs Product and Services
Table 18. Tolmar Urology Drugs Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Global Urology Drugs Sales by Manufacturer (2019-2021e) & (MT)
Table 20. Global Urology Drugs Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 21. Market Position of Manufacturers in Urology Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 22. Global Urology Drugs Production Capacity by Company, (MT): 2020 VS 2021
Table 23. Head Office and Urology Drugs Production Site of Key Manufacturer
Table 24. Urology Drugs New Entrant and Capacity Expansion Plans
Table 25. Urology Drugs Mergers & Acquisitions in the Past Five Years
Table 26. Global Urology Drugs Sales by Region (2016-2021e) & (MT)
Table 27. Global Urology Drugs Sales by Region (2021-2026) & (MT)
Table 28. Global Urology Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 29. Global Urology Drugs Revenue by Region (2021-2026) & (USD Million)
Table 30. Global Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 31. Global Urology Drugs Sales by Type (2021-2026) & (MT)
Table 32. Global Urology Drugs Revenue by Type (2016-2021e) & (USD Million)
Table 33. Global Urology Drugs Revenue by Type (2021-2026) & (USD Million)
Table 34. Global Urology Drugs Price by Type (2016-2021e) & (USD/Kg)
Table 35. Global Urology Drugs Price by Type (2021-2026) & (USD/Kg)
Table 36. Global Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 37. Global Urology Drugs Sales by Application (2021-2026) & (MT)
Table 38. Global Urology Drugs Revenue by Application (2016-2021e) & (USD Million)
Table 39. Global Urology Drugs Revenue by Application (2021-2026) & (USD Million)
Table 40. Global Urology Drugs Price by Application (2016-2021e) & (USD/Kg)
Table 41. Global Urology Drugs Price by Application (2021-2026) & (USD/Kg)
Table 42. North America Urology Drugs Sales by Country (2016-2021e) & (MT)
Table 43. North America Urology Drugs Sales by Country (2021-2026) & (MT)
Table 44. North America Urology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 45. North America Urology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 46. North America Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 47. North America Urology Drugs Sales by Type (2021-2026) & (MT)
Table 48. North America Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 49. North America Urology Drugs Sales by Application (2021-2026) & (MT)
Table 50. Europe Urology Drugs Sales by Country (2016-2021e) & (MT)
Table 51. Europe Urology Drugs Sales by Country (2021-2026) & (MT)
Table 52. Europe Urology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 53. Europe Urology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 54. Europe Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 55. Europe Urology Drugs Sales by Type (2021-2026) & (MT)
Table 56. Europe Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 57. Europe Urology Drugs Sales by Application (2021-2026) & (MT)
Table 58. Asia-Pacific Urology Drugs Sales by Region (2016-2021e) & (MT)
Table 59. Asia-Pacific Urology Drugs Sales by Region (2021-2026) & (MT)
Table 60. Asia-Pacific Urology Drugs Revenue by Region (2016-2021e) & (USD Million)
Table 61. Asia-Pacific Urology Drugs Revenue by Region (2021-2026) & (USD Million)
Table 62. Asia-Pacific Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 63. Asia-Pacific Urology Drugs Sales by Type (2021-2026) & (MT)
Table 64. Asia-Pacific Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 65. Asia-Pacific Urology Drugs Sales by Application (2021-2026) & (MT)
Table 66. South America Urology Drugs Sales by Country (2016-2021e) & (MT)
Table 67. South America Urology Drugs Sales by Country (2021-2026) & (MT)
Table 68. South America Urology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 69. South America Urology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 70. South America Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 71. South America Urology Drugs Sales by Type (2021-2026) & (MT)
Table 72. South America Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 73. South America Urology Drugs Sales by Application (2021-2026) & (MT)
Table 74. Middle East & Africa Urology Drugs Sales by Country (2016-2021e) & (MT)
Table 75. Middle East & Africa Urology Drugs Sales by Country (2021-2026) & (MT)
Table 76. Middle East & Africa Urology Drugs Revenue by Country (2016-2021e) & (USD Million)
Table 77. Middle East & Africa Urology Drugs Revenue by Country (2021-2026) & (USD Million)
Table 78. Middle East & Africa Urology Drugs Sales by Type (2016-2021e) & (MT)
Table 79. Middle East & Africa Urology Drugs Sales by Type (2021-2026) & (MT)
Table 80. Middle East & Africa Urology Drugs Sales by Application (2016-2021e) & (MT)
Table 81. Middle East & Africa Urology Drugs Sales by Application (2021-2026) & (MT)
Table 82. Direct Channel Pros & Cons
Table 83. Indirect Channel Pros & Cons
Table 84. Urology Drugs Typical Distributors
Table 85. Urology Drugs Typical Customers
List of Figures
Figure 1. Urology Drugs Picture
Figure 2. Global Urology Drugs Sales Market Share by Type in 2020
Figure 3. Α (alpha) Blockers
Figure 4. 5 α-reductase Inhibitors
Figure 5. Global Urology Drugs Sales Market Share by Application in 2020
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. Global Urology Drugs Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 10. Global Urology Drugs Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. Global Urology Drugs Sales (2016-2026) & (MT)
Figure 12. Global Urology Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 13. Global Urology Drugs Production Capacity (2016-2026) & (MT)
Figure 14. Global Urology Drugs Production Capacity by Geographic Region: 2020 VS 2021
Figure 15. Urology Drugs Market Drivers
Figure 16. Urology Drugs Market Restraints
Figure 17. Urology Drugs Market Trends
Figure 18. Global Urology Drugs Sales Market Share by Manufacturer in 2020
Figure 19. Global Urology Drugs Revenue Market Share by Manufacturer in 2020
Figure 20. Urology Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 21. Top 3 Urology Drugs Manufacturer (Revenue) Market Share in 2020
Figure 22. Top 6 Urology Drugs Manufacturer (Revenue) Market Share in 2020
Figure 23. Global Urology Drugs Sales Market Share by Region (2016-2026)
Figure 24. Global Urology Drugs Revenue Market Share by Region (2016-2026)
Figure 25. North America Urology Drugs Revenue (2016-2026) & (USD Million)
Figure 26. Europe Urology Drugs Revenue (2016-2026) & (USD Million)
Figure 27. Asia-Pacific Urology Drugs Revenue (2016-2026) & (USD Million)
Figure 28. South America Urology Drugs Revenue (2016-2026) & (USD Million)
Figure 29. Middle East & Africa Urology Drugs Revenue (2016-2026) & (USD Million)
Figure 30. Global Urology Drugs Sales Market Share by Type (2016-2026)
Figure 31. Global Urology Drugs Revenue Market Share by Type (2016-2026)
Figure 32. Global Urology Drugs Price by Type (2016-2026) & (USD/Kg)
Figure 33. Global Urology Drugs Sales Market Share by Application (2016-2026)
Figure 34. Global Urology Drugs Revenue Market Share by Application (2016-2026)
Figure 35. Global Urology Drugs Price by Application (2016-2026) & (USD/Kg)
Figure 36. North America Urology Drugs Sales Market Share by Type (2016-2026)
Figure 37. North America Urology Drugs Sales Market Share by Application (2016-2026)
Figure 38. North America Urology Drugs Sales Market Share by Country (2016-2026)
Figure 39. North America Urology Drugs Revenue Market Share by Country (2016-2026)
Figure 40. United States Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 41. Canada Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Mexico Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Europe Urology Drugs Sales Market Share by Type (2016-2026)
Figure 44. Europe Urology Drugs Sales Market Share by Application (2016-2026)
Figure 45. Europe Urology Drugs Sales Market Share by Country (2016-2026)
Figure 46. Europe Urology Drugs Revenue Market Share by Country (2016-2026)
Figure 47. Germany Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. France Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. United Kingdom Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. Russia Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Italy Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Asia-Pacific Urology Drugs Sales Market Share by Region (2016-2026)
Figure 53. Asia-Pacific Urology Drugs Sales Market Share by Application (2016-2026)
Figure 54. Asia-Pacific Urology Drugs Sales Market Share by Region (2016-2026)
Figure 55. Asia-Pacific Urology Drugs Revenue Market Share by Region (2016-2026)
Figure 56. China Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 57. Japan Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Korea Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. India Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Southeast Asia Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Australia Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. South America Urology Drugs Sales Market Share by Type (2016-2026)
Figure 63. South America Urology Drugs Sales Market Share by Application (2016-2026)
Figure 64. South America Urology Drugs Sales Market Share by Country (2016-2026)
Figure 65. South America Urology Drugs Revenue Market Share by Country (2016-2026)
Figure 66. Brazil Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 67. Argentina Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Middle East & Africa Urology Drugs Sales Market Share by Type (2016-2026)
Figure 69. Middle East & Africa Urology Drugs Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Urology Drugs Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Urology Drugs Revenue Market Share by Country (2016-2026)
Figure 72. Turkey Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 73. Egypt Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. South Africa Urology Drugs Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source